Continuous Glucose Monitoring– tag –
-
Abbott Submits Dual Glucose-Ketone Sensor ‘Libre Duo’ to US FDA for DKA Prevention After European CE Mark
MedTech Dive USA Overview Abbott has filed an FDA application to launch its dual glucose-ketone sensor, Libre Duo, in the U.S. after receiving Europe's CE mark. Approval is expected by year-end, with the device aiming to prevent diabetic... -
UAE Breakthrough: Wearable Ketone Monitor Slashes DKA Emergencies by 60% for Type 1 Diabetics, Poised to Revolutionize Diabetes Management
Facebook UAE Overview Researchers in the UAE have engineered a pioneering wearable continuous ketone monitor (CKM) that tracks interstitial fluid ketone levels to avert diabetic ketoacidosis (DKA) in Type 1 diabetics. A clinical trial in... -
Rising Costs of CGM and Insulin Pumps Threaten Patient Access to Home Medical Equipment in Diabetes Care: AAHomecare Warns
AAHomecare (via Facebook) America Overview Reports indicate that increasing costs for Continuous Glucose Monitoring (CGM) and insulin pumps are impacting access to diabetes care and home medical equipment. Due to largely stagnant reimbur... -
Senseonics Eversense 365 Receives FDA Approval as World’s First Year-Long Wearable CGM, Expanded Medicare Coverage to Reshape Market
Constancy Researchers America Overview Senseonics' Eversense 365 has secured FDA approval, becoming the world's first commercially available year-long implantable continuous glucose monitor (CGM). This innovation fundamentally improves p... -
Wearable Multi-Analyte Biosensors Revolutionize Diabetes Monitoring and Personalized Medicine: A Comprehensive Review of Nanostructured Electrodes and Flexible Substrate Engineering
PMC (Review Article) International Overview This review article details the path to commercializing minimally and non-invasive glucose monitoring, alongside advances in non-invasive real-time analysis of sweat, saliva, tears, and interst... -
Abbott Secures CE Mark for Libre Duo Glucose-Ketone Sensor, Accelerates European Rollout of Consumer Lingo Biosensor
FreeStyle Libre Summer 2026 update Europe Overview Abbott obtained the European CE Mark in May 2026 for Libre Duo and Libre Duo 10 Day, capable of measuring both glucose and ketones for 15 days, with European market launch planned within... -
Non-Invasive Optical Glucose Sensing Advances with In Vivo Raman Platform Validation for Real-World Reliability: 2026 Research Unveiled
Sweet Light Global Overview Despite extensive research and investment, non-invasive optical glucose monitoring lacks FDA-approved products, but a 2026 study validated an in vivo Raman platform in oral glucose tolerance tests, marking sig... -
Abbott and Google Health Announce Multi-Year Partnership to Revolutionize Personal Metabolic Health Management with AI-Powered Glucose Insights
PR Newswire USA Overview Abbott and Google Health have announced a multi-year partnership to integrate glucose insights from Abbott's Lingo biowearables with Google's AI and consumer technology, aiming to make personalized metabolic heal... -
Abbott and Medtronic Announce Global Partnership to Integrate FreeStyle Libre CGM Technology into Medtronic Insulin Delivery Systems
Abbott (via Facebook press release), Medtronic USA Overview Medtronic and Abbott have announced a global partnership to integrate Abbott's FreeStyle Libre sensing technology into Medtronic's insulin delivery systems. Under this agreement... -
Dexcom Stelo Wins FDA Approval as First Prescription-Free OTC Continuous Glucose Monitor for Non-Insulin Users
Dexcom (via Facebook) USA Overview Dexcom's Stelo glucose biosensor system has received FDA approval as the first over-the-counter (OTC) continuous glucose monitor (CGM) for adults aged 18 and older who do not use insulin. This landmark ...
